ÂÜÀòÂÒÂ×

Tom J. Parry, PhD, MBA, BCMAS joined NeuroTrauma Sciences in April 2021 as Senior Vice President of Research and Early Development. Tom is a seasoned drug discovery and development scientist with experience in neurologic disease and other therapeutic areas. With over 27 years in the biopharmaceutical industry, he has held various nonclinical/clinical pharmacology and toxicology scientific leadership roles and managed project teams advancing programs into and through clinical development to market authorization. Most recently, Tom was Vice President of Research and Early Development at Ovid Therapeutics, leading pharmacology and nonclinical safety teams for development of products in neurologic disorders and rare diseases. Previously, he held positions of increasing responsibility at Acorda Therapeutics and Johnson & Johnson, focused on development of programs in neurology, cardiovascular and other therapeutic areas. Throughout his career, Tom has served on numerous NIH study sections, received multiple patents, and authored numerous peer-reviewed publications.

Tom received a B.S. in Chemistry from Moravian College and a Ph.D. in Pharmacology from Temple University and was a post-doctoral fellow in the Pharmacology and Psychiatry departments at the University of Pennsylvania. Tom serves on the Executive and Program Committees and has chaired the Division for Drug Discovery and Development of the American Society of Pharmacology and Experimental Therapeutics. He is Board Certified in Medical Affairs and is an adjunct faculty member at Temple University’s Lewis Katz School of Medicine and School of Pharmacy, where he teaches a graduate course in Pharmaceutical Biotechnology. He formerly held a faculty position for the Harvard/Brown University-sponsored Drug Development Bootcamp, for over 10 years.